Acetate-free blood purification can impact improved nutritional status in hemodialysis patients

Journal of Artificial Organs

Volumn 14, Issue 2, 2011, Pages 112-119

  Matsuyama, Kazuhiro ^a   Tomo, Tadashi ^b,c   Kadota, Jun Ichi ^c  

^a Matsuyama Clinic Oita Nephro Internal Medicine Department   (Japan)

^b OITA UNIVERSITY HOSPITAL   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

Acetate free blood purification; Biocompatibility; Microinflammation; Nutrition

Indexed keywords

BICARBONATE; C REACTIVE PROTEIN; CREATININE; HEMODIALYSIS FLUID; INTERLEUKIN 6; LEPTIN; NEUROPEPTIDE Y; ACETIC ACID DERIVATIVE;

ACETATE FREE BLOOD PURIFICATION; ARTICLE; BICARBONATE BLOOD LEVEL; BIOCOMPATIBILITY; BLOOD PH; CATABOLISM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DOWN REGULATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOFILTRATION; HUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ADULT; AGED; BLOOD; CLINICAL TRIAL; FEMALE; HEMODIAFILTRATION; INFLAMMATION; KIDNEY FAILURE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ACETATES; ADULT; AGED; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; FEMALE; HEMODIAFILTRATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; NEUROPEPTIDE Y; NUTRITIONAL STATUS; RENAL DIALYSIS; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 80055093002     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-010-0551-7     Document Type: Article

References (41)

1. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899-911. (Pubitemid 29197978)
2. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54:627-36. (Pubitemid 28357427)
3. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648-58. (Pubitemid 29082891)
4. Rashid G, Benchetrit S, Fishman D, Bernheim J. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int. 2004;66:1099-106. (Pubitemid 39121015)
5. Kültz D. Hyperosmolality triggers oxidative damage in kidney cells. Proc Natl Acad Sci USA. 2004;101:9177-8. (Pubitemid 38812847)
6. Gerardi G, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, Di LD. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40:104-10. (Pubitemid 34257822)
7. Kawabata K, Nakai S, Miwa M, Sugiura T, Otsuka Y, Shinzato T, Hiki N, Tomimatsu I, Ushida Y, Hosono F, Maeda K. CD31 expression on leukocytes is downregulated in vivo during hemodialysis. Nephron. 2001;89:153-60. (Pubitemid 32830604)
8. Kawabata K, Nagake Y, Shikata K, Fukuda S, Nakazono H, Takahashi M, Ichikawa H, Makino H. Soluble P-selectin is released from activated platelets in vivo during hemodialysis. Nephron. 1998;78:148-55. (Pubitemid 28054983)
9. Filiopoulos V, Vlassopoulos D. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets. 2009;8:369-82.
10. Aucella F, Vigilante M, Gesuete A, Maruccio G, Specchio A, Gesualdo L. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Nephrol Dial Transplant. 2007;22: v8-12.
11. Bossola M, Sanguinetti M, Scribano D, Zuppi C, Giungi S, Luciani G, Torelli R, Posteraro B, Fadda G, Tazza L. Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:379-85.
12. Mion CM, Hegstrom RM, Boen ST, Scribner BH. Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis. Trans Am Soc Artif Intern Organs. 1964;10:110-5.
13. Graefe U, Follette WC, Vizzo JE, Goodisman LD, Scribner BH. Reduction in dialysis-induced morbidity and vascular instability with the use of bicarbonate in dialysate. Proc Clin Dial Transplant Forum. 1976;6:203-9.
14. Grandi, E, Govoni, M, Furini, S, Severi S, Giordano E, Santoro A, Cavalcanti S. Induction of NO synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath. Nephrol Dial Transplant. 2008;23:2192-7. (Pubitemid 351957602)
15. Amore A, Cirina P, Mitola S, Peruzzi L, Bonaudo R, Gianoglio B, Coppo R. Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol. 1997;8:1431-6. (Pubitemid 27491234)
16. Higuchi T, Yamamoto C, Kuno T, Okada K, Soma M, Fukuda N, Nagura Y, Takahashi S, Matsumoto K. A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production. Ther Apher Dial. 2004;8:460-7. (Pubitemid 40082554)
17. Todeschini M, Macconi D, Fernández NG, Ghilardi M, Anabaya A, Binda E, Morigi M, Cattaneo D, Perticucci E, Remuzzi G, Noris M. Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. Am J Kidney Dis. 2002;40:783-93.
18. http://www.kidney.org/professionals/kdoqi/guidelines-updates/ doqiuphd-appx.html
19. Hara M. Calculation of protein catabolic rate using pre-and postdialysis blood urea nitrogen concentration. J JSDT. 2000;33:347-52.
20. http://www.kidney.org/professionals/kdoqi/guidelines-updates/nut-appx02a. html
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
22. National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35:S1-140.
23. Weinhold B, Bader A, Poli V, Rüther U. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo. Biochem J. 1997;325:617-21. (Pubitemid 27367749)
24. Stenvinkel P, Lindholm B. C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif. 2005;23:72-8. (Pubitemid 40082247)
25. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546-9.
26. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs. 2004;27:835-41. (Pubitemid 40484595)
27. Lam MF, Leung JC, Lo WK, Tam S, Chong MC, Lui SL, Tse KC, Chan TM, Lai KN. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Nephrol Dial Transplant. 2007;22:1445-50. (Pubitemid 47072235)
28. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int. 2001;59:1114-20. (Pubitemid 32206875)
29. Kokot F, Chudek J, Adamczak M, Wiecek A. Interrelationship between plasma leptin concentration and severity of metabolic acidosis in haemodialysed patients with chronical renal failure. Exp Clin Endocrinol Diabetes. 2001;109:370-3. (Pubitemid 32977418)
30. Zheng F, Qiu X, Yin S, Li Y. Changes in serum leptin levels in chronic renal failure patients with metabolic acidosis. J Ren Nutr. 2001;11:207-11. (Pubitemid 33601550)
31. Aguilera A, Codoceo R, Bajo MA, Iglesias P, Diéz JJ, Barril G, Cigarrán S, Alvarez V, Celadilla O, Fernández-Perpén A, Montero A, Selgas R. Eating behavior disorders in uremia: a question of balance in appetite regulation. Semin Dial. 2004;17:44-52. (Pubitemid 38376691)
32. Hegbrant J, Martensson L, Thysell H, Ekman R, Boberg U. Changes in plasma levels of vasoactive substances during routine acetate and bicarbonate hemodialysis. Clin Nephrol. 1994;41: 106-12. (Pubitemid 24057168)
33. Juarez-Congelosi M, Orellana P, Goldstein SL. Normalized protein catabolic rate versus serum albumin as a nutrition status marker in pediatric patients receiving hemodialysis. J Ren Nutr. 2007;17:269-74. (Pubitemid 46936233)
34. Tomo T, Matsuyama M, Nakata T, Kadota J, Toma S, Koga N, Fukui H, Arizono K, Takamiya T, Matsuyama K, Ueyama S, Shiohira Y, Uezu Y, Higa A. Effect of high fiber density ratio polysulfone dialyzer on protein removal. Blood Purif. 2008; 26:347-53.
35. Desmeules S, Lévesque R, Jaussent I, Leray-Moragues H, Chalabi L, Canaud B. Creatinine index and lean body mass are excellent predictors of long-term survival in haemodiafiltration patients. Nephrol Dial Transplant. 2004;19:1182-9. (Pubitemid 38628139)
36. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998;31:93-100. (Pubitemid 28116689)
37. Goodman MH. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med. 1994;205:182-5.
38. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol. 2005;98:911-7. (Pubitemid 40283672)
39. Mitch WE. Mechanisms causing loss of lean body mass in uremia. Adv Nephrol. 1997;26:133-42.
40. Lofberg E, Gutierrez A, Anderstam B, Wernerman J, Bergstrom J, Price SR, Mitsh WE, Alvestrand A. Effect of bicarbonate on muscle protein in patients receiving hemodialysis. Am J Kidney Dis. 2006;48:419-29. (Pubitemid 44262432)
41. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20:2075-84.